Paper11288872
Towards a better understanding of the cisplatin mode of action.
Marchán V and 3 others. Chemistry, 2001. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Towards a better understanding of the cisplatin mode of action. Papers, record 11288872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11288872
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Chromatography, High Pressure Liquid | |
| DNA | |
| Peptides | |
| Spectrum Analysis |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40099677 | Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy. | Chempluschem | 2025 | https://conductscience.org/library/papers/40099677 | PubMed |
| 37936720 | Alginate-based hydrogel platform embedding silver nanoparticles and cisplatin: characterization of the synergistic effect on a breast cancer cell line. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37936720 | PubMed |
| 34214537 | Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy. | Biophys J | 2021 | https://conductscience.org/library/papers/34214537 | PubMed |
| 33448132 | On the Heterogeneous Nature of Cisplatin-1-Methyluracil Complexes: Coexistence of Different Aggregation Modes and Partial Loss of NH3 Ligands as Likely Explanation. | ChemistryOpen | 2021 | https://conductscience.org/library/papers/33448132 | PubMed |
| 27891174 | Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. | Chin Med | 2016 | https://conductscience.org/library/papers/27891174 | PubMed |
| 19200747 | The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry. | J Am Soc Mass Spectrom | 2009 | https://conductscience.org/library/papers/19200747 | PubMed |
| 19052781 | Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts. | J Biol Inorg Chem | 2009 | https://conductscience.org/library/papers/19052781 | PubMed |
| 17534671 | Incorporation of two modified nucleosides allows selective platination of an oligonucleotide making it suitable for duplex cross-linking. | J Biol Inorg Chem | 2007 | https://conductscience.org/library/papers/17534671 | PubMed |
| 12774240 | Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail? | Int J Colorectal Dis | 2003 | https://conductscience.org/library/papers/12774240 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11288872
GET https://conductscience.org/api/papers/v1/11288872/authors